Skip to content

Nuvation Bio NUVB Asset turnover

Asset turnover at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×0.0×
Pfizer logo
PfizerPFE
0.3×0.0×
Immunome logo
ImmunomeIMNM
0.0×
Arcus Biosciences logo
Arcus BiosciencesRCUS
0.2×+0.1×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
0.4×+0.3×
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
0.0×

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

Based on trailing twelve months.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's asset turnover?
Nuvation Bio (NUVB) reported asset turnover of 0.3× in Q1 2026.
How has Nuvation Bio's asset turnover changed year-over-year?
Nuvation Bio's asset turnover increased by 1210.1% year-over-year, from 0× to 0.3×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.